Exactech announced the first implantation of the Alteon Tapered Wedge Femoral Stem by orthopedic surgeon Jeffery Pierson, MD.
Spinal Tech
StemCells reported more than $12 million in net losses for the second quarter of 2014, significantly higher than the $5.8 million net loss reported last year.
Stryker Director Ronda E. Stryker sold 21,000 shares of the company's stock on the open market last Friday, following huge sales in July as well, according to a Mideast Times report.
The Food and Drug Administration granted 21 spine-related 510(k) clearance in July.
A new report from Kalorama Information examines the $300 billion-plus global medical device market, finding acquisitions driving growth in the future.
Advertisement
Halifax Biomedical started a research study for its spine instability measurement system in collaboration with Horizon Health Network.
Amsterdam-based Tornier reported $86.9 million in second quarter revenue in 2014, an 11 percent increase over the same period last year.
Minimus Spine successfully secured the CE Certificate for its TrioJection System for delivering ozone to a herniated spinal disc.
Mazor Robotics reported second quarter net loss at $3.7 million on a non-GAAP basis, but company CEO Ori Hadmoi was positive about Mazor's development over the past quarter and anticipates growth in the future.
Zacks Equity Research released a new report on Zimmer post-Biomet acquisition.